What does stable disease mean on my HER2-Positive Breast Cancer scan results

Understanding "Stable Disease" on Your HER2-Positive Breast Cancer Scan

Great question—this is an important term to understand when tracking your cancer response to treatment.

What "Stable Disease" Means

Stable disease means that your cancer is not growing and not shrinking based on what the scan shows. The tumors are essentially staying about the same size compared to your previous scan. This is measured using standardized criteria that radiologists (imaging doctors) apply to compare scans over time.

Think of it this way: if your tumor was 2 cm on your last scan and it's still approximately 2 cm on this scan, that would be considered stable disease.

Why This Matters for HER2-Positive Breast Cancer

For HER2-positive breast cancer specifically, stable disease is actually a meaningful response to treatment. According to NCCN Guidelines for HER2-positive breast cancer, the goal of treatment is to control the cancer and prevent it from growing. Stable disease indicates that your current treatment approach is working to hold the cancer in place.

This is different from:

• Progressive disease (cancer is growing)
• Partial response (cancer is shrinking, but not completely gone)
• Complete response (no visible cancer remaining)

What You Should Do Next

Since you have stable disease, here are important questions to ask your oncology team:

1. "Is my current treatment plan working well for me, or should we consider adjusting it?" Stable disease is good, but your doctor may want to continue, modify, or change your HER2-targeted therapy based on your overall situation.

2. "How often will we scan to monitor my disease?" Your care team will establish a schedule to track whether the disease remains stable, improves, or changes.

3. "Are there any side effects from my current treatment that we should address?" Managing side effects is important for maintaining quality of life during treatment.

4. "What does the complete picture show?" Ask your doctor to explain not just the size measurements, but also any other findings on the scan (like lymph node changes or spread to other areas).

5. "What are the next steps if the disease progresses?" It's helpful to understand what options exist if the cancer begins to grow, so you're prepared for any scenario.

Important Context

According to NCCN Guidelines for HER2-positive breast cancer, treatment decisions are based on multiple factors beyond just scan results:

• Your overall health and how well you're tolerating treatment
• Whether you had any residual disease after initial therapy
• Your specific HER2 status and any other biomarkers
• Your personal preferences and goals of care

Your oncologist will use stable disease as one piece of information to determine whether to continue your current treatment, adjust the dose, or consider other HER2-targeted therapy options (such as trastuzumab, pertuzumab, or ado-trastuzumab emtansine, depending on your specific situation).

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.